Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8535268 | 0.84 | HPGD (0.42) | EPHX1HPGDKMT2AEPHX2LMNA | |
| SCHEMBL8106988 | 0.80 | HPGD (0.42) | EPHX1HPGDKMT2AEPHX2LMNA | |
| SCHEMBL1916162 | 0.78 | LMNA (0.53) | EPHX1HPGDKMT2AEPHX2LMNA | |
| SCHEMBL3069324 | 0.77 | EPHX1 (0.40) | EPHX1HPGDKMT2AEPHX2NPC1 | |
| SCHEMBL14354172 | 0.77 | EPHX1 (0.40) | EPHX1HPGDKMT2AEPHX2NPC1 | |
| SCHEMBL1148328 | 0.76 | EPHX1 (0.54) | EPHX1HPGDKMT2AEPHX2NPC1 | |
| SCHEMBL7945281 | 0.76 | EPHX1 (0.54) | EPHX1HPGDKMT2AEPHX2NPC1 | |
| SCHEMBL19867672 | 0.76 | KMT2A (0.38) | EPHX1HPGDKMT2AEPHX2LMNA | |
| SCHEMBL3656797 | 0.76 | TSHR (0.48) | EPHX1HPGDKMT2AEPHX2LMNA | |
| SCHEMBL4439073 | 0.75 | HPGD (0.41) | EPHX1HPGDKMT2AEPHX2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9579528-B2 | Ketones as perfuming ingredients | FIRMENICH SA (CH) | 2017-02-28 | — | — | US | disclosed |
| US-9579528-B2 | Ketones as perfuming ingredients | FIRMENICH SA (CH) | 2017-02-28 | — | — | US | disclosed |
| US-9579528-B2 | Ketones as perfuming ingredients | FIRMENICH SA (CH) | 2017-02-28 | — | — | US | disclosed |
| US-8841488-B2 | Ketones as perfuming ingredients | FIRMENICH SA (CH) | 2014-09-23 | — | — | US | disclosed |
| US-8841488-B2 | Ketones as perfuming ingredients | FIRMENICH SA (CH) | 2014-09-23 | — | — | US | disclosed |
| US-8841488-B2 | Ketones as perfuming ingredients | FIRMENICH SA (CH) | 2014-09-23 | — | — | US | disclosed |
| US-20140030204-A1 | KETONES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2014-01-30 | — | — | US | disclosed |
| US-20140030204-A1 | KETONES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2014-01-30 | — | — | US | disclosed |
| US-20140030204-A1 | KETONES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2014-01-30 | — | — | US | disclosed |
| EP-2268779-B1 | KETONES AS PERFUMING INGREDIENTS | FIRMENICH & CIE (CH) | 2013-01-02 | — | — | EP | disclosed |
| EP-2268779-B1 | KETONES AS PERFUMING INGREDIENTS | FIRMENICH & CIE (CH) | 2013-01-02 | — | — | EP | disclosed |
| US-20110014143-A1 | KETONES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014143-A1 | KETONES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014143-A1 | KETONES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2011-01-20 | — | — | US | disclosed |
| WO-2009128026-A1 | KETONES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2009-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140030204-A1 | KETONES AS PERFUMING INGREDIENTS | C5, CBR3, C9 | EPHX1 2107/4885HPGD 2163/4885KMT2A 1237/4885 |
| US-20110014143-A1 | KETONES AS PERFUMING INGREDIENTS | CBR3, CBR1, C5 | EPHX1 447/4885HPGD 719/4885KMT2A 1571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.